Annual report 2022

Proposal of the Board of Directors for the appropriation of the available profit

in CHF

 

2022

 

2021

Net profit/(loss) for the year

 

14’269’773

 

–497’618

Unallocated profit carried forward from previous year

 

4’045’272

 

Total available profit

 

18’315’045

 

–497’618

Appropriation from free reserves

 

5’000’000

 

25’000’000

Ordinary dividend

 

–20’457’417

 

–20’457’111

Balance carried forward

 

2’857’628

 

4’045’272

 

 

 

 

 

Dividend distribution per share CHF 0.01

 

 

 

 

Gross dividend

 

0.50

 

0.50

Withholding tax (35%)

 

–0.18

 

–0.18

Net dividend

 

0.32

 

0.32

 

 

 

 

 

Reserves from capital contribution

 

294’653’000

 

294’653’000

Allocation to free reserves

 

 

Balance carried forward

 

294’653’000

 

294’653’000

 

 

 

 

 

Free reserves

 

268’104’248

 

293’104’248

Allocation to balance carried forward

 

–5’000’000

 

–25’000’000

Balance carried forward

 

263’104’248

 

268’104’248

The Board of Directors proposes the payment of a dividend of CHF 0.50 per share to the Annual General Meeting on April 28, 2023. The company will not pay a dividend on treasury shares held by medmix Ltd or one of its subsidiaries.